Hannah Valantine - 31 Dec 2023 Form 5 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
Brian C. Stephenson, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
31 Dec 2023
Net transactions value
+$44,476
Form type
5
Filing time
13 Feb 2024, 16:05:15 UTC
Previous filing
19 Dec 2023
Next filing
18 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Purchase $24,923 +1,891 $13.18 1,891 28 Dec 2021 By Spouse
transaction BBIO Common Stock Purchase $19,553 +1,542 +82% $12.68 3,433 28 Dec 2021 By Spouse
holding BBIO Common Stock 1,764 31 Dec 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.